Autopsy report · NCT03488810

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

“Extended study timelines and additional budget could no longer be supported.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

Radiation Therapy; Apalutamide; Luteinising Hormone Releasing Hormone analog agonist (LHRHa); Non-steroidal anti-androgen

Participants

0

Trials that died the same way

• Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
  “Study stopped due to budget (personnel) limitations.” (70% match in meaning)
• Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
  “Study was stopped due to funding and time constraints.” (70% match in meaning)
• Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)
  “The study was terminated as it was determined to not be feasible to complete enrollment and the study within the required timeline and budget.” (69% match in meaning)
• Muscle, Essential Amino Acids, and eXercise in Heart Failure
  “There is no longer any funding to support the study” (69% match in meaning)
• The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study
  “Study discontinued due to lack of study funding.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.